Zolinza Studies - Zolinza Myeloma Studies - Studies on Zolinza


How is Zolinza currently being studied in myeloma?

Zolinza studies are underway in clinical trials of relapsed and/or refractory myeloma, including:

  • A Phase I/II trial in combination with Revlimid and dexamethasone (RZD) in patients who are no longer responding to Revlimid
  • A Phase I/II trial in combination with Kyprolis (carfilzomib), Revlimid, and dexamethasone (QUAD)
  • In addition, Zolinza is being evaluated as maintenance therapy in patients who have undergone autologous stem cell transplant:
  • A Phase II trial in combination with Velcade, which has completed enrollment
  • A Phase I trial in combination with Revlimid, which has completed enrollment